ValorQ4, 24Total de pasivos683.1 MCapital total2.16 BTotal de pasivos y patrimonio neto2.84 BDeuda total—Deuda neta—
Exelixis Inc
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.